2025 annual financial data
AstraZeneca 2025 Operating margin
Direct answer
Operating margin was 23.4%.
Operating income was 13,743,000,000 USD and net income was 10,255,000,000 USD.
Operating cash flow was 14,575,000,000 USD.
Get free AstraZeneca email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 58,739,000,000 USD
- Operating income
- 13,743,000,000 USD
- Net income
- 10,255,000,000 USD
- Operating cash flow
- 14,575,000,000 USD